The amplification of DNA from Chlamydia trachomatis by PCR with degenerated primers yielded a 345-bp fragment of the putative RNase P RNA gene. From the deduced DNA sequence of this gene in C. trachomatis, a modified primer pair was designed. The primer pair was subsequently used to obtain the corresponding gene products from Chlamydia pneumoniae and Chlamydia psittaci. Sequence comparisons revealed similarities of 76.6% between C. trachomatis and C. pneumoniae, 79.5% between C. trachomatis and C. psittaci, and 84.7% between C. pneumoniae and C. psittaci. Furthermore, the three species were differentiated by fragment length polymorphism analysis after restriction enzyme cleavage of the PCR products. Sequence variations among 14 serotypes of C. trachomatis were confined to one purine base substitution in the putative RNase P RNA gene of lymphogranuloma venereum strains L1 to L3. Complete sequence similarity was found for nine strains of C. pneumoniae of different geographic origins. Taken together, our results indicate a possibility of the general application of this method in clinical bacteriology. Analysis of the secondary structures of the putative RNase P RNA genes from the different Chlamydia species suggested that a novel structural element in the domain of RNase P RNA is involved in base pairing with the 3-terminal CCA motif of a tRNA precursor. This structure has not previously been found among RNase P RNAs of members of the division Bacteria.
Chlamydia is a unique genus that includes three species pathogenic for humans: Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia psittaci. C. trachomatis is the agent of the blinding eye disease trachoma (8) . C. trachomatis is also the agent of sexually transmitted infections, which have sequelae such as ectopic pregnancy and infertility (5) . C. pneumoniae has been established as a cause of community-acquired pneumonia (14) and is associated with acute and chronic coronary heart diseases (24) . The diverse group of C. psittaci organisms are zoonotic, causing respiratory tract infections in humans (1) and affecting a wide range of animals with different clinical manifestations (22) . All three Chlamydia species cause respiratory tract infections (1, 14, 29) and are involved in heart infections (23) . Thus, although not valid for most chlamydial infections, there is a need in clinical diagnostics to discriminate between different Chlamydia species.
Ribozymes are RNA molecules with enzymatic activity which catalyze their own cleavage or that of other RNA molecules. RNase P is a ribonucleoprotein complex which endonucleolytically removes 5Ј leader sequences from tRNA precursors. RNase P is present in all living cells, and either the enzyme or RNase P activity has been demonstrated in a wide range of prokaryotes and eukaryotes, as well as in mitochondria and chloroplasts (4) . In members of the division Bacteria the enzyme is composed of an approximately 400-nucleotide-long RNA molecule (11, 26) and a protein of about 120 amino acids (18) . The RNA is the catalytic subunit of RNase P; however, so far only RNase P RNA derived from the Bacteria functions alone as an efficient catalyst in vitro (17) .
Sequences of the RNase P RNA gene from representatives of different bacterial groups are highly diverse, with similarities of only 35 to 55% (4). However, the variability within species has been poorly investigated, and the potential role of this variability in discriminating between bacterial strains has not been analyzed to any significant extent. Sequencing of the RNase P RNA genes provides a tentative tool for the identification of bacteria and eukaryotic organisms in clinical diagnostics and may be used for strain differentiation in studies of molecular epidemiology. In this report we describe the putative RNase P RNA gene sequences of three species of the genus Chlamydia, including 14 different serotypes of C. trachomatis, nine strains of C. pneumoniae, and two strains of C. psittaci. Differentiation of Chlamydia species was shown by specific restriction fragment length polymorphism (RFLP) patterns after enzymatic cleavage. We also discuss the features of the secondary structure of RNase P RNA in Chlamydia species and compare these with those of the RNase P RNAs of other bacteria.
MATERIALS AND METHODS
Bacterial strains. DNAs of C. trachomatis serotypes A, B, C, D, E, F, G, H, I, J, K, L1, L2, and L3 (all except I and L2 were generously provided by K. Persson, Malmö, Sweden) were extracted from cultures in embryonated hen eggs. C. pneumoniae target DNA was obtained from clinical isolates (isolates P1, JG915, and JG954) at the Department of Clinical Microbiology, Uppsala, Sweden; purchased from the American Type Culture Collection (isolate VR1356); or kindly provided by C. Black, Atlanta, Ga. (isolates CM1, CWL011, CWL029, and CWL050), and B. Berdal, Oslo, Norway (isolate FML16). C. psittaci DNA was prepared from the egg-cultured type strain 6BC of avian origin and a clinical isolate (isolate 5BS; provided by M. Domeika, Uppsala, Sweden) from bull semen. Extraction included standard procedures with Triton X-100 and proteinase K incubation and then phenol-chloroform treatment and spin column purification (Microcon 100; Amicon, Beverly, Mass.).
PCR amplification of the RNase P RNA gene. The RNase P RNA gene in C. trachomatis was amplified by PCR with the degenerated primers BM1 and BM2 by using two gene regions of conserved nucleotides as the 3Ј primer ends (Fig. 1) . The 5Ј end of primer BM1 was biotinylated for single-stranded solid-phase sequencing with Dynabeads (Dynal, Oslo, Norway) (19) . The first 15 nucleotides in the 5Ј end of the BM2 primer were the universal Ϫ21 M13 sequence (5Ј-TGT AAA ACG GCC AGT-3Ј), which was used as a handle for dye primer sequencing with T7 DNA polymerase (Sequenase; Amersham, Little Chalfont, United Kingdom). For solid-phase sequencing of the complementary strand, the same target-specific primer sequences were used, but the biotinylation and M13 handle were shifted. The concentration of biotinylated primers was 0.1 M, and that of the nonbiotinylated primers was 0.3 M. The DNA amplification consisted of an initial denaturation step at 95ЊC for 3 min; this was followed by 35 cycles of denaturation at 94ЊC for 45 s, annealing at 43ЊC for 45 s, and synthesis at 72ЊC for 1 min. The amplification was completed with a prolonged synthesis at 72ЊC for 5 min.
For sequencing of C. pneumoniae and C. psittaci DNAs, a PCR product was generated with primers BH1 and BH2 ( Fig. 1) , and for the complementary DNA strand, their counterparts were sequenced with the shifted biotinylation and the M13 handle. In order to achieve a balanced melting temperature with the primer carrying the M13 handle, the biotinylated primers also included a clamp of six cytosine nucleotides at their 5Ј ends. PCR amplification of the RNase P RNA genes of C. pneumoniae and C. psittaci was performed as described for C. trachomatis RNase P RNA, except that the annealing temperature was 42ЊC for the first 5 cycles and 58ЊC for the remaining 30 cycles.
Sequencing of DNA. Nucleotide sequences were determined with an Applied Biosystems model 373A automated DNA sequencer and were analyzed with DNA Star sequence software (DNA Star, London, United Kingdom).
Analysis of amplified DNA. Five microliters of the amplified PCR mixture was analyzed by 1.0% (IBI/Eastman, New Haven, Conn.) or 4% (1:3 ratio of DNAgrade agarose to NuSieve GTG agarose; FMC, Rockland, Maine) agarose gel electrophoresis directly or after restriction enzyme digestion, respectively. The DNA was visualized by ethidium bromide staining and with UV fluorescence. Differentiation of the three Chlamydia species was achieved by examination of the RFLP patterns of the PCR product obtained from the BH1-BH2 primer pair. The 15-l amplicon was cleaved with 10 U of the endonuclease AluI or 5 U of the endonuclease AccI (Boehringer Mannheim, Mannheim, Germany) for 3 h at 37ЊC.
Nucleotide sequence accession numbers. The nucleotide sequences presented in this report have been submitted to GenBank and have been given the accession numbers U44031 (C. trachomatis), U44032 (C. psittaci), and U44033 (C. pneumoniae).
RESULTS
PCR amplification of DNA from C. trachomatis with the BM1-BM2 primer pair yielded a 345-bp fragment of the putative RNase P RNA gene, with the 5Ј end at position 55 of the corresponding gene in Escherichia coli. No PCR products were obtained when the same primer pair was used for different strains of C. pneumoniae and C. psittaci. By using a target sequence deduced from C. trachomatis, primers BH1 (with the 5Ј end corresponding to position 17 in C. trachomatis; Fig. 2 ) and BH2 were designed, and when these primers were used, a 327-bp fragment of C. pneumoniae and a 323-bp fragment of C. psittaci were obtained. Analysis of the sequences revealed that the corresponding RNA strands could be folded into structures similar to the secondary structure of RNase P RNA (Fig. 2 ) (4). This suggests that these DNA fragments are derived from the gene encoding RNase P RNA in the Chlamydia species analyzed.
The guanine-plus-cytosine contents of the determined sequences were 38.9% for C. psittaci, 41.2% for C. pneumoniae, and 43.4% for C. trachomatis, which is close to the reported guanine-plus-cytosine contents of the complete genomic DNAs of Chlamydia species (10) . Analysis of the three sequences showed similarities of 76.6% between C. trachomatis and C. pneumoniae, 79.5% between C. trachomatis and C. psittaci, and 84.7% between C. pneumoniae and C. psittaci. Thus, in comparison with the sequence of the 16S rRNA genes derived from the same species (12) , the sequences of the RNase P RNA genes showed lower levels of similarity. The heterologous base positions that differentiated the three Chlamydia species were found in several regions of the gene, but particularly in the P12 domain (nucleotides 100 to 107 [Fig. 3] ; for identification of P12, P17, and P19, see Fig. 2 ), in loop P17 (nucleotides 219 to 242), and in the P19 stem-loop structure (nucleotides 300 to 322).
Computer analysis of possible endonuclease cleavage sites revealed several RFLP patterns distinguishing the three Chlamydia species. Cleavage of the PCR product from the RNase P RNA genes with AluI resulted in two fragments for C. trachomatis (137 and 213 bp) and four fragments for C. pneumoniae (42, 42, 75, and 189 bp), while for C. psittaci enzymatic digestion gave two fragments (137 and 207 bp). Similarly, digestion with AccI gave two fragments for C. trachomatis (32 and 318 bp), no cleavage for C. pneumoniae, and three fragments for C. psittaci (32, 156, and 156 bp) (Fig. 4) . Application of the RFLP technique to the RNase P RNA genes resulted in differentiation of the three Chlamydia species pathogenic for humans. This indicates that these sequence differences can be used in diagnostic applications.
In order to find heterologous base positions among different strains of C. trachomatis, the sequences of the RNase P RNA genes of 14 serovars, A to K and L1 to L3, were determined. The only difference detected was a replacement of the guanosine residue at position 158 (Fig. 2) in serovars A to K by an adenosine residue in serovars L1 to L3. This position is located in the distal part of the stem-loop in the P14 region.
Comparison of nine C. pneumoniae strains, isolated from patients with respiratory tract infections in the United States, Sweden, and Norway, did not reveal any sequence differences in the RNase P RNA genes (data not shown). Similarly, the two C. psittaci strains of avian and bull semen origins had identical sequences (data not shown).
DISCUSSION
Comparison of the primary sequences of 16S RNA has identified the Chlamydiaceae family as a phylogenetic group of organisms unique among the division Bacteria (28). In RNase P RNA, the secondary and tertiary structures rather than the nucleotide sequence constitute the conserved elements and provide knowledge about phylogenetic relationships (7). The similarities of the primary sequences of closely related species are, however, comparable (4). Positions with different nucleotides were found in extensive parts of the RNase P RNA genes of the three Chlamydia species. When stem residues were substituted, this was mostly accompanied by a corresponding shift at the base-pairing nucleotide position. Since stems and loops maintain their secondary structures and since the functions of most loops in the RNase P RNA gene are poorly defined in all bacterial species, it is difficult to judge the significance of the observed sequence differences between the Chlamydia species.
Surprisingly, the members of the primer pair BM1 and BM2 (Fig. 1) , which have universally conserved 3Ј ends, did not FIG. 1. Schematic representation of the RNase P RNA gene and oligonucleotide sequences used in PCR amplifications of chlamydial RNase P RNA genes. The Ϫ21 M13 sequence, used as a target in sequencing with universal dye primers, is illustrated as 5Ј tails of the primers. F, biotinylation for singlestranded rescue. Positions refer to nucleotide number in the proposed RNase P RNA secondary structure in C. trachomatis in Fig. 2. FIG. 2 . Suggested secondary structures of RNase P RNA in C. trachomatis, the minimum consensus bacterial RNase P RNA, and E. coli RNase P RNA (M1 RNA). The two latter structures are according to Brown et al. (3) . The nucleotides in the primer sequences are in lowercase type, m indicates an adenine-cytosine mixture, and r indicates adenine-guanine mixture in this position. N denotes tentative nucleotides in the flanking regions of the primers based on M1 RNA. The numbering of the bases in C. trachomatis RNase P RNA refers to the numbering in Fig. 3 . Key to consensus: GAUC, 100% conserved; gauc, 90% conserved; F, nucleotides present in all RNAs; E, nucleotides present in 90% of RNAs.
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on July 6, 2017 by guest http://jcm.asm.org/ amplify the RNase P RNA genes of C. pneumoniae and C. psittaci. When the primer sequence of BM1 was shifted 16 bases downstream and the deduced C. trachomatis sequence was used, however, PCR products were obtained for both C. pneumoniae and C. psittaci. This could be due to mismatching of nucleotides in the 5Ј end of the primer, although it was degenerated in this segment, or, less likely, one of the conserved nucleotides at the 3Ј end might have differed in C. pneumoniae and C. psittaci. The levels of similarity of the analyzed RNase P RNA gene sequences between the three Chlamydia species ranged from 77 to 85%. In contrast, the previously reported degrees of homology of the almost 1,600-bp 16S RNA sequences in Chlamydia species ranged between 91 and 96% (12) . Thus, for the differentiation of closely related Chlamydia species, the RNase P RNA genes provide a higher degree of resolution than the 16S RNA genes, which can in fact be identical in separate species (9) . When more distantly related species are to be compared, the differences in the lengths of the RNase P genes make the analysis less straightforward.
The heterologous RNase P RNA gene sequences in Chlamydia species provided several RFLP patterns that distinguished the three species from one another. Cleavage by AluI or AccI restriction enzymes could easily differentiate the Chlamydia species from one another (Fig. 4) . This offers a method of clinical application when the differentiation of Chlamydia species is required. Furthermore, our data suggest that both RFLP and sequence determinations of the RNase P RNA genes have general applications for the differentiation of all bacterial species. This renders the RNase P RNA gene as a tool for widespread diagnostic use in clinical microbiology. Significant differences in the structures of the RNase P RNA genes derived from the intracellular bacterium Rickettsia prowazekii and the various Chlamydia RNase P RNA genes are also apparent (26a). Therefore, it is also possible to distinguish between the intracellular pathogens of Chlamydia and Rickettsia species by using the RNase P RNA gene sequences.
With the high degree of variability of the RNase P RNA genes in the Chlamydia species examined, it was of interest to determine sequence differences among strains of the same species. Analysis of 14 serotypes of C. trachomatis disclosed a one-base difference positioned at the distal part of the P14 stem-loop (Fig. 2) . This purine substitution was conferred to the lymphogranuloma venereum strains that cause genital ulcers and lymphoadenopathy, diseases rarely seen in developed countries, and that cause clinical entities distinct from those of the sexually transmitted infections caused by serotypes A to K (25) .
No heterology was observed when the RNase P genes from nine C. pneumoniae strains were sequenced. Sequencing of a 1,305-bp amplicon from the 16S RNA genes of eight C. pneumoniae isolates of human origin revealed an altered nucleotide at only one base position (2) . Complete sequence homology between different C. pneumoniae strains has been shown for variable domain IV of the major outer membrane protein gene omp-1 (13) , which in C. trachomatis is highly variable and is the gene that distinguishes the 15 serotypes (30) . Total concordance has also been found for the sequence of the 60-kDa outer membrane protein-encoding gene omp-2 in different C. pneumoniae isolates but not in C. trachomatis strains (27) . Thus, C. pneumoniae isolates of human origin are likely to be homogeneous with respect to several biological features and may possibly have evolved later than C. trachomatis. This has impeded the typing and differentiation of C. pneumoniae strains, and there is still a need for a method that permits molecular epidemiological investigations of C. pneumoniae isolates in the community.
Analysis of the secondary structures of the Chlamydia RNase P RNAs suggested a novel structure in the P15 region which previously has not been observed among bacterial RNase P RNAs. More specifically, the GGGUA sequence (positions 291 to 295 in E. coli; Fig. 5 ), which is part of an internal loop, is replaced by a bulge structure in the different Chlamydia species, as indicated in Fig. 5 . The well-conserved nucleotides from position 292 (G residue) to 294 (U residue) have recently been shown to form base pairs with the 3Ј-terminal CCA sequence of tRNA precursors in E. coli as well as in Mycoplasma hyopneumoniae (20, 26b) , and it is suggested that this interaction anchors the substrate to the ribozyme, which consequently results in an unfolding of the acceptor-stem of the tRNA precursor as well as cleavage at the correct position. The CCA sequence is encoded in all tRNA genes of E. coli and in the majority of tRNA genes in other bacterial species that have been examined (15; see also reference 16 and references therein). Only a few tRNA genes from C. trachomatis have been identified and sequenced; however, these do not encode the 3Ј-terminal CCA (6) . Thus, if this is the case for all tRNA genes in Chlamydia species, then a region which can form a base pair with the 3Ј-terminal CCA motif in Chlamydia RNase P RNA is not necessary. This might indicate that the interaction between Chlamydia RNase P RNA and its substrate is different from what has been found in other species of the division Bacteria. We also note that the secondary structure in this region of C. trachomatis RNA resembles the structure of the archaebacterium Sulfolobus acidocaldarius (Fig. 5) , which has not been demonstrated to be catalytic in the absence of the protein subunit of RNase P (21) . Therefore, an intriguing question is whether Chlamydia RNase P RNA alone is catalytic. We are addressing this question. Another interesting observation is that the highly conserved nucleotide 24 in Chlamydia species was uracil, whereas a cytosine residue has been found in more than 90% of known sequences among the Bacteria (3) . The U at nucleotide 24 has also been found in Thermotoga maritima (7), a representative of the earliest divergence in the bacterial lineage. It has been suggested that both of the genera Thermotoga and Chlamydia diverged from the bacterial root early (6) .
To conclude, the RNase P RNA genes of C. trachomatis, C. pneumoniae, and C. psittaci have been characterized and have been shown to have heterologous sequences that allow for the easy differentiation between the species on the basis of RFLPs. Analysis of the RNase P RNA genes provides a new alternative to previously used targets for the detection and typing of Chlamydia species, and the results indicate a possibility of general application in clinical bacteriology.
